SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
IREN (IREN.US) Q1 FY2027 Earnings Call: CEO Responds to Microsoft Corporation Delivery Delays; Over US$4 Billion ARR Target Postponed to January Next Year
Hunan Friendship & Apollo Commercial (002277.SZ): Restructuring matter to be reviewed at a meeting on November 12
Dongguan Mentech Optical & Magnetic (002902.SZ)'s application for issuing shares to specific targets has been accepted by the Shenzhen Stock Exchange.
IREN (IREN.US) Q1 FY2027 Earnings Call: CEO Responds to Microsoft Corporation Delivery Delays; Over US$4 Billion ARR Target Postponed to January Next Year
Hunan Friendship & Apollo Commercial (002277.SZ): Restructuring matter to be reviewed at a meeting on November 12
Dongguan Mentech Optical & Magnetic (002902.SZ)'s application for issuing shares to specific targets has been accepted by the Shenzhen Stock Exchange.
